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Systematic Study of Amyloid Beta Peptides: Implications for Alzheimer’s Disease  
 
Jeffy Jiménez 
ABSTRACT 
 
The amyloid beta peptide particularly the 40 and 42 amino acid residues are the 
responsible for plaque formation in Alzheimer's disease (AD) patients. Extra cellular 
plaque formation has been recognized after incessant investigations along with the 
formation of intracellular tau protein tangles as the hallmarks of AD. Furthermore, the 
plaque formation has been linked mostly as a cause of the disease and the tangles mostly 
as a consequence. Our investigation is focused on studying the formation of AD plaques. 
The amyloid beta (Aß) is a physiological peptide secreted from neurons under normal 
conditions, along with other soluble forms cleaved from the amyloid precursor protein 
(APP). These soluble forms of APP have neuroprotective and neurotrophic functions, 
while the Aß is considered an unwanted by-product of the APP processing. Under normal 
conditions there is an anabolic/catabolic equilibrium of the Aß peptide; therefore, it is 
believed that the formation of the plaque does not take place. On the other hand, the 
neurons' surface may play an important role in the adhesion mechanisms of the Aß 
peptide. Our experiments show that the neuron surfaces along with the media conditions 
may be the most important causes for progressive formation of plaques. We have 
 ix
incubated rigid supports (mica) and soft biomimetic substrates (lipid bilayers on top of a 
PEG cushion layer drafted onto a silica surface) with the three different conformations of 
the Aß peptide (monomeric, oligomeric and fibrils structures) to determine the adhesion 
mechanisms associated with in situ plaque formation. The soft biomimetic substrates 
have been assembled first by depositing and activating a thin film of silica (i.e., to create 
surface silanol groups). This film is then reacted with polyethylene glycol (PEG), which 
is a biocompatible polymer, to create a cushion-like layer that supports and allows the 
lipid bilayer to have high mobility. A lipid bilayer is then deposited on this soft support to 
reproduce a cell membrane using the Langmuir Blodgett deposition technique. The 
characterization of such biomimetic membranes has been studied by using Atomic Force 
Microscopy (AFM) in liquid environments. Our results show that these lipid bilayers are 
highly mobile. Additionally the structure and topography characteristics of the Aß 
conformations have been followed with atomic force microscopy (AFM). The kinetics 
and rates of adhesion have been measured with attenuated total reflection Fourier 
transform infrared (ATR-FTIR) spectroscopy. Our results show the progress of the 
plaques' formation with time where simple monomers deposit on the substrates and allow 
the development of oligomeric species. The oligomers then grow into fibril-like 
structures leading finally to the plaques that eventually are seen to insulate real neurons 
and stop them from the synapse process. The ultimate outcome of this investigation will 
contribute to understand, prevent and determine possible mechanisms for removing AD 
plaques.  
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Chapter One 
Introduction 
1.1.  Alzheimer’s Disease   
Worldwide the most common cause of senile dementia is Alzheimer’s disease 
(AD), an age-associated neurodegenerative disease characterized by loss of memory and 
language skills, damage cognitive function, and altered behavior. The first AD’s clinical 
symptoms are typically seen after the age of 65 years old [1].  
After the age of 85, one out of every two people is affected either by AD or by 
what is called a mild cognitive impairment (MCI) condition [2].  MCI is recognized by a 
significantly reduced memory with cognition being within a normal range and is 
considered as a symptom indicating the onset of dementing disorders primarily 
represented by AD [2]. More than 15% of the cases of MCI turn into Alzheimer’s disease 
[3]. The estimated number of AD’s cases is over 20 million worldwide and is expected to 
keep growing as the world population ages [2].  
The pathologic mechanisms of Alzheimer’s disease are  still uncertain, however 
two hallmarks are recognized: intracellular neurofibrillary tangles (NFTs) and 
extracellular senile plaques [4]. The NFTs are structures composed  of paired helical 
filaments mainly formed of abnormally hyperphosphorylated tau protein (P-TAU) [5] 
which is mainly but not exclusively neuronal microtubule-associated protein (MAP) [6]. 
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Some of the roles of the tau protein are: stabilization of axonal microtubules, signaling 
transduction, interaction with the actin cytoskeleton, and neurite outgrowing. The 
formation of this NFT is believed to be a consequence of the amyloid plaque formation 
[2]. Figure 1 shows both deposit of plaques and NFT. The extracellular senile plaques are 
composed by amyloid peptide deposits of mainly 40- and 42-amino acids long (Aβ1-40 
and Aβ1-42) [5]. Amyloid-β peptides do not appear to play a major physiological role 
indeed the based on the original amyloid cascade hypothesis amyloid plaque depositions 
or partially aggregated soluble Aβ trigger a neurotoxic cascade, thereby causing 
neurodegeneration and finally pathology of AD [7]. 
 
Figure 1. Two of the Alzheimer’s Disease Hallmarks: (left) A High-power 
photomicrograph of an amyloid plaque; (right) A photomicrograph of silver stained 
(black) neurofibrillary tangles in the cell bodies [7] 
 
The plaques and tangles are accumulated in neurons throughout the cortical and 
limbic brain regions [5] (regions shown in Figure 2). The cortical region is responsible 
for the abilities and activities related to our thinking, some examples are language and 
abstract thinking, it is also involved in basic aspects of perception, movement, and 
adaptive  response to the outside world [8]. The limbic region is primarily responsible for 
our emotional life and the formation of memories [8].  
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Based on the studies over the years a hypothesis involving plaque formation has 
been proposed and studied. The amyloid-β hypothesis  sustains that the main cause of AD 
is the presence of this protein as the main component of  the plaques that block the 
synapses in the neuronal cells [9].  A historical report about the discoveries that relate AD 
with amyloid-β peptides is shown in Appendix A.  
 
Figure 2. Regions in the Brain Affected by AD 
 
The amyloid-β is a physiological peptide is secreted from the neurons under 
normal conditions in addition with other soluble peptides that are cleavaged from the 
transmembrane amyloid precursor protein (APP). APP consists of a large extracellular N-
terminal domain and a smaller intracellular tail (Figure 3). Apparently the soluble forms 
of APP have neuroprotective and neurotrophic functions. However, Aβ is considered as 
an unwanted by-product of the APP processing [2].  
The Aβ peptides are found as globular and non-fibrillar forms in small 
concentrations of pico- to nano-molar, and are found in the extracellular and cytoplasmic 
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(inside the cell) regions in both normal as well as AD tissues.  Nevertheless, significantly 
small oligomeric molecules, and non-fibrillar Aβ peptides, are sufficient to cause 
profound cytoskeletal degeneration and cell death through mechanisms of plaque’s 
formation still not completely understood.  
 
Figure 3. Synthesis of Aβ in the Cell.   The β-amyloid domain is partly embedded in the 
plasma membrane. To generate Aβ, APP is first cleaved by β-secretase, resulting in the 
release of β-secretase-cleaved soluble APP (β-sAPP). In the second step, the 99 amino 
acid C-terminal fragment (C99 CTF) is cleaved by the γ-secretase complex releasing free 
β-amyloid[3] 
 
The Aβ peptides are found as globular and non-fibrillar forms in small 
concentrations of pico- to nano-molar, and are present in both extracellular and 
cytoplasmic (inside the cell) regions in both normal as well as AD tissues. Nevertheless, 
significantly small oligomeric molecules, and non-fibrillar Aβ peptides, are sufficient to 
cause profound cytoskeletal degeneration and cell death through mechanisms of plaque’s 
formation still not completely understood.  
 Under normal conditions, in the brain there is an anabolic/catabolic equilibrium of 
the amyloid-β peptide; that prevents the formation of AD plaques [2]. However, once this 
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equilibrium is broken, the protein progressively aggregates causing the plaque formation 
[2].  There are more than 13,000 publications [10] concerning Aβ peptide have shown 
different approaches to treat and prevent AD. These studies involve genetics and 
molecular biology, among other approaches. However, among all these publications little 
has been done about the interacting mechanisms of the proteins structures with the cell 
membrane. In this thesis, we conduct systematic investigations to elucidate the 
mechanisms between protein and membrane structures under different physiological 
conditions (i.e., varying the pH, temperature of the media, and the composition of the 
membrane). The surface of the neurons plays an important role in the adhesion 
mechanisms of Aβ; mechanisms associated with a cascade of events that may begin with 
the aggregation of monomer (seed) as bigger molecules (oligomers) that eventually result 
in larger structures (fibril) that accumulates on the cell membrane forming plaques 
blocking synaptic processes. It is believed that this surface coating leads to intracellular 
tangles formation and finally to neuron death. Our approach is to mimic cell conditions 
changing the media and characterizing the structure formation and the interaction 
mechanisms of these forms using a biomimetic cell membrane.  
1.2. Significance of this Work 
This work represents a contribution to the “amyloid hypothesis” investigation, 
that not only states that AD is characterized by the reduction and increase levels of 
sAPPα and Aβ respectively when the APP metabolism is altered, but also views other 
abnormalities in AD as either leading to Aβ plaque formation/deposition [11].  We are 
mainly focused in answering two questions:  
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a. What are the intermolecular forces and kinetic mechanisms involved in the 
formation of the different amyloid-β (Aβ40 and Aβ42) peptide 
conformations (i.e., monomeric, oligomeric and fibril)? 
b. What are the surface interactions between amyloid-β peptide 
conformations and cell membranes, and their role in plaque formation? 
Therefore, this work will elucidate ways that may lead to plaque prevention 
and/or removal, based on the understanding of neurotoxic structures assemble, and 
surface energy features, in connection with the medium and the interacting substrate 
conditions.   
1.3. Research Aims  
 This work has been divided in three main aims: 
1.3.1. First Aim  
 To study and compare conformation assembly for Aβ (1-40) and Aβ (1-42): This 
will be done by looking at the stability of the monomeric state and the formation and 
stability of oligomers and fibrils.  Many studies have proven the medium influence on the 
amyloid peptide conformations [12-16]. Therefore, we need to find a reproducible 
conformational assembly scheme based on the medium conditions employed, these are 
controlling pH, temperature, and incubation time. This study is done for the two 
characteristic peptides found in the Alzheimer’s disease patients, Aβ (1-40) and Aβ (1-
42).  We are using the Atomic Force Microscopy (AFM), which allows one to visualize 
the structures with a resolution within nanometers, giving topological details of the 
structures. 
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1.3.2. Second Aim  
To study and understanding of oligomeric and fibrillar kinetics: In order to 
properly understand the adhesion mechanisms of Aβ conformations to the cell membrane 
that drive to plaque formation, it is needed to understand first their kinetics of its 
formation. This study is conducted using the Attenuated Total Reflection Fourier 
Transform Infrared (ATR-FTIR) spectroscopy.  This technique allows one to recognize 
the structural chemistry of the molecules under study in real time.  
1.3.3. Third Aim  
To study the adhesion mechanisms: This aim is subdivided in two stages:  
a. The study of adhesion behavior of monomeric, oligomeric and 
fibrillar forms with variable substrates looking at the substrate 
rigidity or softness dependency. This study is done by coupling 
AFM and ATR-FTIR analysis. 
b. To analyze the dominant processes during the aggregation of the 
three Aβ conformations by deconvolution of the ATR-FTIR 
spectra and the relationship of the topography ratios of the AFM 
scans. For this specific aim different substrates have been used 
such as mica, and biomimetic cell membranes constructed by 
assembling lipid bilayers. 
1.3. Structure of this Thesis 
For a systematic study of the interactions between Aβ and membrane surfaces it is 
needed to know some basic concepts concerning molecular biology, biological 
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interaction forces, and cell membrane (interface properties), which will be described in 
Chapter two among other basic concepts.  
A brief description of the systems that have been studied are presented in Chapter 
three. The interest on looking at the monomeric, oligomeric and fribrillar conformations 
and their relationship to AD are also explained. Additionally, a concise explanation 
involving biomimetic cell membrane structural design is described. 
 Chapter five illustrates the technical details of this investigation and all the 
protocols followed in the preparation and characterization of the systems.  
 The results and discussion of this work are presented in chapter six, as well as a 
comprehensive analysis of the data.  
 The conclusions for this work along with the final suggestion and future work are 
presented in Chapter seven.  
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Figure 4. L and D Isomers of Amino Acids (R refers to the side chain). The L and 
D isomers are mirror images of each other 
 
 
 
Chapter Two 
Fundamentals in Biochemistry and Cell Biology  
2.1. Amino Acids 
Amino acids are the building blocks of proteins. A so-called α-amino acid 
consists of a central carbon atom, called the α carbon, linked to an amino group, a 
carboxylic acid group, a hydrogen atom, and a distinctive R group. The R group is often 
referred to as the side chain. Because of the four different groups connected to the 
tetrahedral α-carbon atom, α-amino acids are chiral; the two isomers are called the L 
isomer and the D isomer (Figure 4).  Only L amino acids are constituents of proteins [17]. 
Essentially, 20 amino acids are components of protein in living organisms. The properties 
displayed by proteins, which in one way or another mark the path of protein aggregation, 
come from amino acid features such as the capacity to polymerize, novel acid-based 
properties, varied structure and chemical functionality in the amino acid side chains, and 
chirality [18]. 
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2.2. Peptide  
Peptide is the name assigned to short chains of amino acids with less than fifty 
amino acid residues [17]. A common classification for peptides uses the number of amino 
acid units in the chain. That is, each unit in the protein chain is called an amino acid 
residue, whereas a chain of amino acids is called a sequence. The word residue comes 
from the act of residing, after an amino acid forms a peptide linkage upon joining a 
peptide chain. For instance, a peptide is a short chain with two amino acid residues, 
tripeptides are formed by three residues and so forth. Since the terminology becomes 
burdensome after 12 residues, the peptide chains with more than 12 and less than about 
20 amino acid sequences are referred to as oligopeptides. According to this terminology, 
only when the chain exceeds 20 amino acids in length, the term polypeptide is then used 
[18]. 
2. 3. The Peptide Bond 
Peptides and proteins are sequential and unbranched polymers of amino acids 
linked head to tail. In every instance, a carboxyl group is linked to an amino group 
through a type of covalent amide linkage referred to as peptide bonds [18]. When a 
peptide bond is formed, the reaction releases water molecules. 
The peptide “backbone” of a protein follows a repeated sequence –N-Cα-C-, 
where the N represents the amide nitrogen, and the Cα  is the α-carbon atom of an amino 
acid in the polymer chain. A schematic of the peptide backbone is shown in Figure 5 
[18]. 
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The geometry of the protein backbone is somewhat responsible for the unique 
qualities that proteins attain. For instance, the peptide bond is essentially planar, and has 
what it is considered a double-bond strength (although it is not a double-bond in essence) 
that prevents free rotation around it.  Also, the peptide bond is uncharged, the absence of 
charge allows tightly packing of amino acid chains, linked by peptide bonds, into 
globular structures [17]. Even though peptide bonds only lost or gain protons at extreme 
pH conditions, the overall charge of a protein can be induced by changing the pH of the 
media [18]. 
In contrast with the peptide bond, the bonds between the amino group and the α-
carbon atom, and between the α-carbon atom and the carbonyl group are mainly single. 
This causes two adjacent rigid peptide units to rotate about these bonds only and allows 
the residues to take various orientations with respect to each other in the chain. 
Consequently, the proteins can fold in scores of different ways owing to the free rotation 
between two each amino acid groups in the chain [17]. 
 
Figure 5. The Peptide Bond Shown in its Usual Trans-Formation of Carbonyl O and Amide 
H. The Cα atoms are the α-carbon of two adjacent amino acids joined in a peptide linkage. 
The dimensions and angles are average values observed by crystallography analysis of 
amino acids and small peptides.  The peptide bond is stippled 
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2.4. Proteins 
In brief, the term protein defines molecules composed of one or more polypeptide 
chains.  Proteins having only one polypeptide chain are monomeric proteins.  Proteins 
composed of more than one polypeptide chain are multimeric proteins or oligomeric.  
Amyloid-β and other fibril-like proteins are called homomultimeric proteins, since they 
only contain one kind of polypeptide. Heteromultimeric proteins are composed of several 
different kinds of polypeptide chains. Multimeric proteins are usually designated by 
Greek letters and subscripts to denote their polypeptide composition such as in the case of 
β-amyloid [18]. 
2.5. Architecture of Protein Molecules  
The architecture of proteins is usually arranged as follows:  
2.5.1. Protein Shape 
Proteins can be organized according to their basic of shape. That is, they can be 
fibrous or globular.  Fibrous proteins tend to have relatively simple, regular linear 
structures, such as β-amyloid fibrils.  These proteins often have structural roles in cells 
(e.g., collagen and fibrinogen).  Typically, they are insoluble in water or in dilute salt 
solutions. In contrast, globular proteins are roughly spherical. The polypeptide chain is 
compactly folded in globular proteins, so that hydrophobic amino acid side chains are in 
the interior of the molecule and the hydrophilic side chains are at the outside of the 
molecule. Hence, globular proteins are very soluble in aqueous solutions.[18] 
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Figure 6. Amyloid β (1-42) Peptide Visualized as a Simple Amino Acid Sequence 
of 42 Residues 
2.5.2. Levels of Protein Structure 
To cope with the complex architecture of protein molecules, they have been 
classified in several levels depending on their structural conformation.  
a. Primary Structure 
The amino acid sequence is the primary structure of a protein. A schematic 
representation of this conformation is shown in Figure 6 [18]. 
b. Secondary Structure 
Secondary structures are one level higher than primary structures and represent a 
three-dimensional arrangement of the polypeptide in space [18]. Polypeptide chains can 
arrange themselves into characteristic patterns by means of hydrogen bonding 
interactions between adjacent amino acid residues. These patterns can appear as helical or 
pleated segments as shown in Figure 7. These segments constitute regular structures that 
extend along one dimension, like the coils of a spring.  Most proteins exhibit this type of 
structures, and depending on the medium conditions they arranged themselves as α-helix 
or β-sheet structures. Amyloid peptide structures are usually described in this 
classification. 
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Figure 7. Two Structural Motifs Arrange the Amino Acid Sequence into a Higher 
Level of Organization Predominantly: The α-helix and the β-pleated strand. Atomic 
representations of these secondary structures are seeing. The flat, helical ribbon is used 
for the α-helix and the flat, wide arrow is used for β-structures. Both of these structures 
own their stability to the formation of hydrogen bonds between the N-H groups and the 
O=C functions within the polypeptide backbone 
c. Tertiary Structure 
A higher level of structure is generated when polypeptide chains assume a more 
compact three-dimensional shape by bending and folding.  For instance, ternary structure 
allows proteins to adopt a globular. Ternary structures are usually seen in those proteins 
commonly existing in cells. The globular conformation promotes a lower surface-to-
volume ratio and shields the protein from interacting with the solvent [18]. 
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d. Quaternary Structure 
Many proteins consist of two or more tertiary structures. Each of these tertiary 
structures is commonly referred to as a subunit of a protein. This subunit organization in 
proteins constitutes yet another level in the hierarchy of protein structure [18]. 
2.6. Amyloid-β Peptide and Protein Denature Process  
The term amyloid was introduced in 1854 by the German physician scientist 
Rudolph Virchow. In his studies, he analyzed cerebral corpora amylocea that had an 
unusual and abnormal appearance when seen under the microscope.  Virchow concluded 
that the substance responsible for such macroscopic abnormality was cellulose and 
named it “amyloid”, derived from the Latin amylum and the Greek amylon that means 
“starch”. Later on, Friedreich and Kekule demonstrated the presence of protein in a 
“mass” of amyloid and pointed the high nitrogen content and absence of carbohydrates. 
Several events have led to the study of amyloid from a single type of protein to a class of 
proteins with propensity to undergo distinct changes in conformation (denature), hence 
resulting in fibril formation .[19] 
For instance amyloidoses are fundamentally diseases related to denatured 
proteins. The propensity to denature of such proteins may be enhanced by mutation, 
environmental factors or posttranslational modifications. Additionally, some proteins are 
“natively denatured” or conformationally mutable. Cells contain elaborate machinery to 
ensure that proteins fold properly, such machinery includes proteins such as chaperones 
and processes such as selective degradation systems. The proteasome is a degradation 
system that disposes of misfolded proteins. A characteristic that distinguishes amyloids 
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Nonpolar tail Polar head
Figure 8. Representation of an 
Amphiphilic Molecule: Sodium 
Palmitate 
from other misfolded or denatured proteins is their ability to aggregate into higher order 
oligomeric and fibrillar structures that allows them to evade quality control systems such 
as the proteasome. Inhibition of the proteasome or lysosomal1 degradation systems can 
lead to the accumulation of misfolded amyloidogenic proteins and peptides. Amyloid 
aggregates also inhibit the proteasome2, most likely by adopting stably folded structures 
that cannot be unfolded and therefore cannot be transported into the central catalytic pore 
of the proteasome enzyme complex.  It is thought that the critical initiation or nucleating 
event in the formation of amyloid is the aggregation of stable β-sheet structures that may 
form a seed. This system grows and propagates owing to the amyloid structure’s 
relatively resistance to degradation in vivo and the 
concentration of aggregation of misfolded 
proteins.  Thus, a small increase in the 
concentration of misfolded proteins can 
dramatically accelerate the onset of AD. [20] 
2.7. Amphiphilic Molecules 
The concept of amphiphilic character is very important because the amyloid-β 
peptide and the lipids forming the cell membrane show this behavior. Amphiphilic 
molecules are compounds that consist of both strongly polar and strongly nonpolar 
groups. The name amphiphilic comes from the Greek amphi meaning “both”, and philos 
meaning “loving.  They are also referred to as amphipathic molecules from the Greek 
                                                 
1 Lysosomal: a membrane-bound cavity in living cells that contains enzymes that are responsible for 
degrading and recycling molecules. 
2 Proteasome: a cluster of proteins found in the cytoplasm of living cells that degrades damaged or 
redundant proteins. 
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Figure 9. Micelle Formation by Amphiphilic Molecules in Aqueous Solution 
pathos meaning “passion, suffering”. Salts of fatty acids are typical examples of 
amphiphilic molecules that have special biological relevance. They have a nonpolar 
hydrocarbon tail and a strongly polar carboxyl head group, such as sodium salt palmitic 
acid (Figure 8).  Their behavior in aqueous solution reflects the combination of the polar 
and nonpolar nature of these substances. The ionic carboxylate component hydrates 
readily, whereas the long hydrophobic tail is intrinsically insoluble.  Because of this, 
sodium palmitate, a soap, shows little tendency to form a true ionic solution in water.   
Nevertheless, sodium palmitate and other amphiphilic molecules readily disperse 
in water because the hydrocarbon tails of these substances are joined together in 
hydrophobic interactions as their polar carboxylate functions are hydrated in typical 
hydrophilic fashion. 
The term micelle refers to a cluster of amphiphatic molecules (Figure 9).  The 
amphipathic behavior of biomolecules has an enormous biological significance.  The 
polar ends express their hydrophilicity by means of ionic interactions with the solvent, 
whereas the nonpolar ends are excluded from water and clustered into a hydrophobic 
domain constituted by the hydrocarbon tails of many of these molecules.  Membranes are 
structures that define the limits and comportments of cells. [18] 
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2.8. Biomolecular Interactions 
Molecules are formed by covalent bonds that allow atoms to hold together and thus 
to form molecules. Weak chemical forces work mainly in intramolecular or 
intermolecular attractions between atoms, such as hydrogen bonds, Van der Waals forces, 
ionic bonds, and hydrophobic interactions [18].  Each force is described below. 
2.8.1. Van der Waals Attractive Forces are the result of induced electrical 
interactions between closely approaching atoms or molecules as their 
negatively charged electron clouds fluctuate instantaneously in time.  These 
fluctuations allow attractions to occur between positively charged nuclei and 
the electron density of the incoming atom [18]. 
2.8.2. Hydrogen Bonds are formed between a hydrogen atom covalently bonded 
to an electronegative atom (such as oxygen or nitrogen) and a second 
electronegative atom that serves as the hydrogen bond acceptor. Hydrogen 
bonds are stronger than Van der Waals forces (as Table 1 shows) and have 
an additional property. That is, H bonds tend to be highly directional, 
forming straight bonds between donor, hydrogen, and acceptor atoms[18].  
Hydrogen bonds are also more specific than van der Waals interactions 
because they require the presence of complementary hydrogen donor and 
acceptor groups. This type of bond has a remarkable influence in the 
possible structures that a molecule can adopt.  
2.8.3. Ionic Bonds are the result of attractive forces between oppositely charged 
polar molecules, such as negative carboxyl groups and positive amino 
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groups.  Since the opposite charges are restricted to sterically defined 
positions, ionic bonds can impart a high degree of structural specificity.[18] 
2.8.4. Hydrophobic Interactions are due to the strong tendency of water to 
exclude nonpolar groups or molecules.  Hydrophobic interactions arise from 
water molecules which prefer and share stronger interactions with one 
another. Since the strongest chemical interaction that is possible between 
two molecules actually determines its properties, the preferential hydrogen 
bonding interactions between polar water molecules excludes nonpolar 
groups. It is this exclusion of nonpolar groups that drives their tendency to 
cluster in aqueous solution. Thus, nonpolar regions of biological 
macromolecules are often in the molecule’s interior of the system, so that 
they are excluded from the aqueous environment. [18] 
One of the reasons why living systems are restricted to a narrow range of 
environmental conditions is due to the fact that weak forces are present in biomolecular 
interactions. Biomacromolecules are functionally active only within a narrow range of 
media conditions, such as temperature, ionic strength, and alkalinity.  Extremes situations 
of these conditions disrupt these weak forces, which are essential to maintaining the 
intricate structure of macromolecules.  The loss of structural order in these complex 
macromolecules is called denaturation, and it is inevitably accompanied by loss of 
functionality. [18] 
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Table 1. Comparison of Biomolecular Interactions 
Force Strength 
(kJ/mol) 
Distance 
(nm) 
Description 
Van der Waals 
interactions 
0.4 - 4.0 0.2 Strength depends on the relative size of the 
atoms or molecules and the distance between 
them. The size factor determines the area of 
contact between two molecules. That is, the 
greater the area, the stronger the interaction. 
Attractive VDW forces are inversely 
proportional to the sixth power of the 
distance, r, separating two atoms or 
molecules: F ≈ 1/r6.  
Hydrogen 
bonds  
12 – 30 0.3 Relative strength is proportional to the 
polarity of the H bond donor and H bond 
acceptor.  More polar atoms form stronger H 
bonds. 
Ionic bonds 20 0.25 Strength also depends on the relative polarity 
of the interacting charged species.  Some 
ionic bonds are also H bonds: 
−− −+ OOCNH ...3  
Hydrophobic 
interactions  
< 40  - Force is a complex phenomenon determined 
by the degree to which the structure of water 
is disordered as discrete hydrophobic 
molecules or molecular regions coalesce.  
 
2.9. The Neuron Cell Membrane  
As it has been explained so far, the Aβ plaques are found on the surface of the 
neurons, hence it is important to identify what else is present on their surface. Therefore, 
the neuron cell membrane is the outer most surface facing the plaques and defines the 
boundaries that separates the inside and outside of the neuron cell. A lipid bilayer makes 
the backbone of cell membranes. 
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Membranes resemble supramolecular complexes in their construction since they 
are complexes of proteins and lipids maintained by covalent forces (Figure 8). 
Some proteins traverse the lipid layer and influence the cell membrane structure. 
Some are for structural support, whereas others are receptors, channels or tunnels that 
allow passage of certain molecules into and out of the cell. Thousands of these channels 
populate the cell membrane and allow passage of the ions. For instance, sodium is a 
major player to the neuron cell because of its positive charge. This ion flows across the 
membrane in different ways depending on the exact status of excitation of the neuron. 
Additionally, in the case of cell membranes, the hydrophobic interactions are particularly 
important in maintaining the membrane structure.  These interactions reflect the tendency 
of nonpolar molecules to come together as they are excluded by a polar solvent. [18] 
Direction 
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To next 
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Figure 10. Schematic Representation of a Neuron Picturing the Cell Membrane 
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Aβ(1-40)                                          Aβ(1-42) 
Figure 11. Alzheimer’s Disease Amyloid-β Peptide Monomer Theoretical 
Configuration
 
 
 
Chapter Three 
Chemistry and Conformations: Amyloid Peptide and Cell Membrane 
3.1. Amyloid-β Peptide Conformations 
3.1.1. Monomers 
Monomers are about 1.0 ± 0.3 nm in size [16], with a molecular weight of: 4329.9 
Da for Aβ (1-40) and 4514.1 Da for Aβ (1-42) (Appendix E). Monomers present mostly 
random coils and α-helix secondary structures (Figure 7).  
The conformation of Aβ (1-40) and Aβ (1-42) single monomers can be visualized 
in Figure 11. These models have been generated using a comparative modeling online 
resource called 3D-JIGSAW (version 2.0). For this program, the source protein sequence 
is entered and then a mathematical model is developed based upon the potentials data that 
its bank holds assuming that there are not internal or solvent interactions whatsoever. The 
complete sequences for the Aβ (1-40) and Aβ (1-42) are provided in appendix E. 
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Monomers are highly stable in fluorinated alcohols including 
hexafluoroisopropanol (HFIP) and trifluoroethanol (TFE). These alcohols disrupt 
hydrophobic forces in aggregated amyloid preparations, and promote α-helical secondary 
structures [16].  By dissolving Aβ peptides in 100% HFIP, the resulting structures for Aβ 
(1-40) and Aβ (1-42) solutions are mostly α-helical (~50-70%) and random coil (~30-
50%), with a little β-sheet secondary structures (<1%) [16].  
3.1.2. Oligomers 
The oligomers also known as protofibrils are considered by several authors [21-
23] as intermediate configurations in the fibrillogenic process. Oligomers are soluble 
spherical aggregates of 2-20 nm and have been study for many different types of 
amyloids with electron and atomic force microscopy [16, 20]. These spherical 
conformations appear at intermediate times of monomeric incubation and disappear as 
fibrils appear, suggesting that they are an intermediate step in the pathway of fibril 
formation. Their sizes vary depending on the number of monomer aggregates. The size of 
this quasi-stable intermediate aggregate  ranges from dimmers up to particles of a million 
Da or greater and have been observed by a several techniques including SDS gel 
electrophoresis, fluorescence resonance  energy transfer, light scattering, and atomic 
force microscopy [16, 20].  
3.1.2. Fibrils 
Many proteins assemble into amyloid fibrils, even those that are not disease 
related.  Amyloid fibrils are approximately 6-10nm in diameter. The unbranched fibrils 
are characterized by a “crossed β-sheet” structure (Figure 7) in which the polypeptide 
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Figure 12. Pathway of Aβ Aggregation and Fibril Formation. 
chain is oriented perpendicularly to the fiber axis with the hydrogen bond parallel to the 
axis. The ability to form amyloids is not limited to disease related proteins. Rather, it 
appears to be a fundamental polymer motif of the polypeptide backbone, although it is 
not commonly observed in native proteins.  Specific sequences or side chain interactions 
are not required for amyloid formation, since many different polyamino acids form 
crossed β-sheet amyloid fibers. This also suggests that the fundamental tendency to form 
amyloids is overcome by the fact that specific sequences tend to adopt stable structures 
with time. 
3.2. Common Pathways of Aggregation amyloid-β peptide  
One particular hypothetical pathway for Aβ fibril assembly is depicted in Figure 
12. The earliest event in the process of aggregation is the formation of dimmers. Aβ 
derived from a segment of APP is believed to be predominantly α-helical in its native 
state. On the other hand, monomeric Aβ is largely conformed as random coil in solution. 
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The formation of Aβ dimmers coincides with the adoption of partial β structure. The Aβ 
dimmers assemble into higher order aggregates or oligomers, since there is a remarkable 
increase in the amounts of higher order aggregates and a decrease in the amount of 
dimmers.  
These higher order Aβ aggregates are protein micelles with a hydrophobic core 
and a polar exterior that appear as 3 nm spherical particles determined by atomic force or 
electron microscopy [20].  
At later times, these spherical shape particles appear to form curvilinear strings or 
“protofibrils”. The protofibrils undergo a conformation change to form the straight, 
unbranched mature fibrils.  Once the amyloid fibril lattice has been established, the fibril 
can grow by the addition of Aβ monomer or dimmer at the ends of the fibril. The higher 
order aggregates have molecular weights ranging from approximately 105 to 106 Da and 
with an average size corresponding to approximately 24 monomers. Aβ oligomers that 
appear as spherical particles are approximately 3 nm in diameter and have the 
characteristics of a protein amphipathic, since it lowers the surface tension of water. 
Formation of high molecular weight aggregates displays a critical concentration of 
approximately 25µM [20] and it is correlated with the formation of a new hydrophobic 
environment. At longer incubation times, the oligomers also appear to co-aggregate to 
form curvilinear fibrils with a characteristic beaded appearance. The spherical oligomers 
and protofibrils appear to be intermediates in the pathway of fiber formation because they 
disappear as mature fibrils accumulate and the rate of monomer dissociation from them is 
too slow to account for fibril growth. The transition appears to involve a major 
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conformational change, because fluorescence quenching analysis indicates that the 
carboxyl terminus is highly shielded from the aqueous solvent in the soluble oligomeric 
state, whereas it is exposed to the solvent in the fibrillar state.  Once the amyloid fibril 
lattice has been established, it can grow by the addition of monomers onto the ends of the 
fibrils. [20] 
 Additionally, numerous in vitro studies have indicated that Aβ oligomers are toxic 
to cells or interfere with the normal function of neurons [21-23]. Mounting evidence 
indicates that soluble amyloid oligomers are generally toxic for a wide variety of disease 
related amyloids. Moreover, soluble oligomers are intrinsically toxic even though they 
are formed by proteins that are not disease related.  The idea that soluble Aβ oligomers 
may play a primary role in AD pathogens is attractive, however, the evidence to support 
it is largely correlative and derived from in vitro toxicity studies.  In order to evaluate the 
role of soluble Aβ oligomers in diseased human brain, there needs to be a way to 
distinguish them from soluble Aβ monomer, APP and Aβ fibrils.  All of these species 
contain the same amino acid sequence, but differ in conformation [20]. These 
conformations are analyzed separately in this work.  
3.3. Biomimetic Cell Membrane 
Biomimetic cell membranes are used to represent the neuronal surface. This cell 
membrane model interacts in vitro with the three conformations of the amyloid-β 
explained above and is built with features of real cell membranes. 
A double layer of lipids molecules makes up the main substance of the cell 
membrane. Lipids containing phosphorus in their head group are called phospholipids. In 
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the cell membrane, some molecules such as cholesterol (there are mainly three types of 
cholesterol lipids: phosphoglycerides, sphingolipids, and sterols), and proteins are located 
between the phospholipids. Cholesterol is known to strengthen the membrane and 
promotes rigidity. A variety of different proteins float within the phospholipids. Some 
proteins act as receptors in the cell, that is, as points of attachment for materials coming 
to the cell in the blood or tissue fluid. Additionally, enzymes are also participating in 
reactions occurring at the plasma membrane.  Some are transporters, shuttling materials 
into or out of the cell, and some form channels through which only selected substances 
can pass. Carbohydrates are present in small amounts, combined either with proteins or 
with lipids. These carbohydrates cells help to recognize each other and to adhere to one-
another. A representation of a model cell membrane is shown in Figure 13 [24].  Lipid 
bilayers are represented by outer, hydrophilic (exposed to an aqueous environment) and 
inner, hydrophobic (maintains a barrier to solute movement) domains. Inserted through 
the membrane or in either inner or outer planes are various proteins that permit transport, 
 
 
Figure 13. Model of a Prototypical Cell Membrane. 
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cell-to-cell and signal molecule interactions, and linkage of the membrane to the 
intracellular cytoskeleton along with cholesterol and carbohydrate molecules. 
Additionally, most biological membrane lipids are composed by double-chained 
phospholipids or glycolipids with 16 to 18 carbons per chain, one of which is unsaturated 
or branched. These properties are not accidentally but carefully design by nature to 
ensure:  
a. Biological lipids will self-assemble into thin bilayer membranes that can 
compartmentalize different regions within a cell, as well as protect the 
inside of the cell from the outside. 
b. Because of their extremely low critical micelle concentration (CMC) the 
membranes remain intact even when the bathing medium is grossly 
depleted of lipids. 
c. Due to unsaturation or branching, the membranes are in the fluid state at 
physiological temperatures which let them deliver various molecules 
through them. 
The construction of the membrane for this work will be done on a substrate such 
that it allows the lipid bilayer to be in a mobile state, supported by a soft cushion. Such 
conditions simulate the real conditions of cell membranes. Preliminary studies involving 
just a simple lipid bilayer were performed. However, future work involves the addition of 
a new component to the bilayer to tune its mobility and surface conformation. We will 
also study the response of these model membranes the three different conformation of the 
amyloid β peptide (i.e., monomers, oligomers and fibrils). 
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Chapter Four 
4. Experimental Methodology and Characterization Techniques 
4.1. Surface Deposition Techniques 
 Two deposition techniques are mainly used in this work, one is a chemical vapor 
deposition based on oxidation reaction and the other is a physical deposition based on 
interacting forces. Both deposition techniques are described below.  
4.1.1. Plasma Enhanced Chemical Vapor Deposition 
Plasma enhanced chemical vapor deposition (PECVD) is a thin film deposition 
method that is used to deposit thin film on metals and other materials that cannot sustain 
high temperature. It takes place at relatively low temperatures (< 300 ºC) due to the use 
of a radio frequencies (RF) source that induces a plasma discharge to transfer energy into 
the reactant gases. The ionized gas (plasma) breaks down the gases and the activation 
energy barrier is lowered forming radicals (decomposition). These radicals produce many 
instable and stable species in the vapor phase, which then react with each other to form 
heavy stable molecules and deposit into a film.   
In this work, PECVD is utilized to deposit a thin layer of silica (i.e., silicon 
dioxide (SiO2)) that is later use as the substrate for a reaction with polyethylene glycol 
(PEG) that ultimately serves as the cushion support for the biomimetic model 
membranes. 
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Figure 14. General Schematic Diagram of a Plasma Enhanced Chemical Vapor 
Deposition Reactor 
 
Figure 15. Water Plasma is Induced 
over the Silica Surface to Create Active 
SiOH Species that React with PEG to 
Produce a Soft Polymeric Support for 
the Model Membranes 
The silica films are produced by reacting SiH4 and O2 gases in this reactor (Figure 
14). The plasma is produced by a helical resonator discharge source using RF powered 
copper coil at 13.56 MHz [25]. 
PECVD is also used to produce water 
plasma (see Figure 15). Water plasma 
treatments are used to increase the hydroxyl 
group concentration on the silica surface 
controllably and reproducibly.  The conditions 
for this process were established previously, so 
that  the silica surface is completely saturated 
the surface with hydroxyl groups, without 
roughening the surface [25].  
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Figure 16. Types of Deposition Using LB Based on the Order of Layers. 
  4.1.2. Langmuir-Blodgett Deposition 
The Langmuir Blodgett deposition technique is used to deposit compact and fine 
organized monolayers. The molecules that are deposited can be organic or inorganic, but 
with amphiphilic nature. The monolayer is formed on the surface of the subphase (water) 
by dissolving the amphiphilic substance in a suitable solvent. In this investigation 
chloroform is used to dissolve the lipids that form the monolayer on the water surface.  
Once the monolayer is formed the deposition takes place upward or downward 
depending on the nature of the substrate and on the type of deposition that is been 
pursued (See Figure 16). The deposition is explained in more detail in the next Chapter. 
 Bilayers or multilayer can be deposited with this sophisticated technique but 
simple. The deposition of the biomimetic cell membrane is constructed as the type Y 
(Figure 16). However, we have a PEG monolayer instead of an initial monolayer of 
lipids. 
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4.2. Physical and Chemical Characterization techniques 
4.2.1. Atomic Force Microscopy (AFM) 
The Atomic Force Microscope 
(AFM) also known as Scanning Force 
Microscope (SFM) or Scanning Probe 
Microscope (SPM). This technique 
allows one to visualize topographies of 
samples in very small ranges with 
resolution of about 10 pm [26].  The 
AFM technique operates by measuring 
attractive or repulsive forces between a 
tip and the sample. As the tip is drag through the sample surface a profile of heights is 
constructed as function of the cantilever deflection lectures that are translate into a real 
image of the surface under study [26].  There are two types of operational modes: contact 
and non contact.  In its repulsive "contact" mode, the instrument lightly touches a tip at 
the end of a leaf spring or "cantilever" to the sample, moreover in contact mode the AFM 
measures hard-sphere repulsion forces between the tip and sample; this mode is mostly 
use when working in solid-liquid interfaces. In non contact mode, the AFM derives 
topographic images from measurements of attractive forces; but the tip does not touch the 
sample. This is also referred as tapping mode and it is mostly used for solid-gas 
interfaces.  In this investigation where used both modes, due to the characteristic of the 
Z Piezo
Cantiliver
Sample
Segmented 
Photodiode 
Detector
X-Y Piezo
Stage
Figure 17. Atomic Force Microscope 
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medium as will be explained in the following chapter.  Figure 17 shows a schematic 
representation of a common AFM. [26] 
4.2.2. Attenuated Total Reflectance Fourier Transform Infrared 
(ATR-FTIR) Spectroscopy  
 Infrared spectroscopy is being widely use for the analysis of peptides and proteins 
due to its reliability of probing the universally available amide (peptide) bonds, which 
show a distinct IR signals for differently folded peptides and proteins [27]. 
 Fourier transform infrared (FTIR) spectroscopy has being predominantly utilized 
to study the secondary structure (α-helix and β-sheets) of proteins in recent years.  
Proteins or polypeptides have a continuous chain of amino acids connected via amide 
bonds also known as the “peptide bond”.  The frequency at which amide bond vibrations 
occur can be attributed to different secondary structures in which the amide bonds are 
present. The differences in vibration of the amide bonds are due to different hydrogen 
bonding among amino acid residues (see Appendix D.2).  For instance, α-helix and β-
sheet folding have ordered hydrogen bonding, although differing in their patterns.  The 
differential pattern in H-bonding, along with geometric orientations of amide bonds in α-
helix, β-sheet, and random coil structures allows the different vibration frequencies 
associated with individual secondary structural folding. Amide vibrations (see Appendix 
D.1) in-plane mode involve C=O stretching, C-N stretching, N-H stretching and O-C-N 
bending, while an out-of-plane mode is due to C-N torsion [28]. These vibrations result in 
characteristic spectral features of proteins. Three major spectral regions (amide I, amide 
II, and amide III) have been identified based on theoretical and experimental studies [27]. 
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 The amide I vibration region, (1700-1600 cm-1), has been widely used due to its 
strong signal exhibited by proteins in this region. However, there are several difficulties 
encountered in this region when analyzing protein spectra. The first difficulty 
encountered in this region is the OH vibrations caused by liquid water and water vapor 
that need to be subtracted out of the protein solution spectrum. Another problem is the 
difficulty of peak assignments. Since there is a greater deal of overlapping of peaks 
representative of the different secondary structures, it is difficult to assign bands to their 
correct structure. For example, bands at 1650-1655 cm-1 could be assigned either to α-
helix or random coil. Using the amide III region (1220-1320 cm-1), many of these 
problems are resolved. In the amide III region, OH vibrations due to water do not 
interfere with spectrum in the amide III region as much as in the amide I region. The 
overlapping of bands arising from different secondary structure of a protein is not 
significantly encountered in this region.  In the amide I region, the frequencies at which 
the different amide bond vibrations occur are not as localized as they are in amide III. In 
the amide III region, various spectral bands are more resolved in the original protein 
spectrum than they are in the amide I spectra. This fact allows a greater ease in peak 
refinement, as well as in peak assignment. The only drawback in using amide III is that 
the protein signal is significantly weaker than the signal obtained in the amide I region 
[27] as is shown in Figure 18, where two proteins has been superimposed: α-
chymotrypsin, and fibrils of Aβ1-42 (this was a sample taking after 10 hours of 
preparation).   
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Figure 18. IR Spectrum of α-Chymotrypsin (black line), and Fibrils of Aβ1-42 (in 
blue). The amide I region (1600-1700cm-1) corresponds to the C=O stretch weakly 
coupled with C-N stretch and N-H bending. The amide II region (1500-1600 cm-1) 
represents C-N stretch strongly coupled with N-H bending. The amide III region 
(1200-1350cm-1) is N-H in-plane bending coupled with C-N stretching and also 
includes C-N and N-H deformation vibrations 
Because IR spectroscopy does not affect protein and peptide samples either in 
solid or liquid form, it can be used for data collection.  Two types of sample accessories 
are typically used: Windows such as calcium fluoride, and attenuated total reflectance 
(ATR) accessory, generally made of zinc selenide or germanium.  For protein absorption 
studies, or for studies with solid powder and thin films, ATR accessory is most 
commonly used for sampling.  One of the advantages of ATR technique in recording 
protein spectrum is the avoidance of solvent interference in IR spectra, because it limits 
the effective sample thickness to a thin layer near the surface of an internal reflection 
crystal (Figure 19) [27].  
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Figure 19. Schematic Diagram of Light Undergoing Multiple 
Reflections in an ATR - FTIR Spectrometer 
Once the spectra are obtained, protein band positions are identified after spectral 
processing by Fourier self-deconvolution and/or second-order derivatization. A variety of 
software packages are available commercially.  
 The data obtained from the deconvolved and second- derivative spectra are used 
to determine the number of bands and their positions in order to resolve the protein 
spectrum into their components. 
This is accomplished with a curve-fitting process employing computer software 
commercially available from the manufacturers of IR instruments.  The software resolves 
the original protein spectrum to individual bands that fit the spectrum. Two main 
parameters control the fitting process: (1) the individual bands, and (2) the baseline 
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position.  Each individual band in turn is controlled by three parameters:  
a. The height of the band. 
b. The position of the band (wavenumber). 
c. The bandwidth at half-height.   
The program iterates the curve-fitting process, and each iteration flows (increases or 
decreases) each parameter (height, bandwidth, position and baseline) to determine 
individual parameters in order to achieve the best Gaussian, Lorentzian, or a mixture of 
Gaussian/Lorentzian-shaped curves that fit the original protein spectrum. A best fit is 
determined by the root mean square (rms) of differences between the original protein 
spectrum and the strength of individual bands. In order to estimate the strength of 
individual band, the band area or intensity is used to calculate the relative contribution of 
each band(s) to a particular secondary structure of the protein. 
 Additionally the fractional areas of the fitted component bands are directly 
proportional to the relative proportions of structure that they represent. The percentage of 
helices, β-structures and turns may be estimated by addition of the areas of all of the 
components bands assigned (after deconvolution) to each of these structure (based on the 
specific wavelengths this structures are) and expressing the sum as a fraction of the total 
area [28]. 
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Chapter Five 
Experimental Design and Procedures 
 Regarding the reagents used in the experiments, section 5.1 describes most of 
these in Table 2. Details about peptide composition can be found in Appendix E. Table 3 
describes the instrumentation and related materials. 
5.1. Reagents and Materials  
Table 2. Primary Reagents Used 
Reagents Acquired From   Appearance 
Amyloid-β peptide (1-40)  Aβ(1-40) American Peptide INC White powder 
Amyloid-β peptide (1-42)  Aβ(1-42) American Peptide INC White powder 
1,1,1,3,3,3-Hexafluro-2-
Propanol (pa: >99%) 
HFIP Fisher Sci. ACROS Org. Viscous- Transparent 
Liq. 
Methyl Sulfoxide 
Anhydrous (p:>99%) 
Me2SO or 
DMSO 
Fisher Sci. ACROS Org. Transparent Liq. 
Dulbecco's Phosphate 
Buffered Saline powder 
PBS MP.Biomedicals White powder 
Tris (Crystallized) p:>99%) Tris Fisher Sci. ACROS Org. White powder 
Polyethylene glycol 
(400Da)  
PEG Sigma Transparent Liq. 
1,2-Dipalmitoyl-sn-
Glycero-3-Phospho-
ethanolamine-N-     
DSPE 
(lipid) 
Avanti Polar Lipids, INC. Powder partially 
dissolve in chloroform 
Ammonium hydroxide NH3OH Fisher Sci. ACROS Org. Transparent Liq. 
Hydrochloric acid (HPLC) HCl Fisher Sci. ACROS Org. Transparent Liq. 
Sodium chloride NaCl Fisher Sci. ACROS Org. White fine granules 
Sodium hydroxide NaOH Fisher Sci. ACROS Org. White pellets 
a purity 
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The water used for all the experiments is ultra purified and obtained from a 
Millipore Water (Milli-Q) station with a resistance <18MΩ, and organics content <5ppb. 
Table 3. Instrument Description and Miscellaneous Materials 
Material / instrument Description 
Centrifuge Fisher Sci., model AccuSpin-400 
Laminar flood cabinet Forma Sci., 95 fpm & 98 fpm 
Vortex Fisher Sci., Volts 120 Vac, Watts 150, 50/60 Hz 
Atomic Force Microscope 
(AFM) for gas/solid Int. DI Dimension 3000. Tapping Mode.  
Cantilevers Silicon. Nanosensors INC. R= 0.01-0.025 Ohm/cm, L=132 µm,  
diam.=15nm, fo=281-339 kHz, k=28-54 N/m. 
AFM liquid/solid Int. Asylum Res. Corp. Contact mode.  The cantilever used is special for contact mode, and is made of  
Cantilevers SiN. L=60µm, diam.=>80nm, fo=37-13 kHz, k=0.027-0.006 N/m
FTIR Spectrometer Nicolett, FT-IR 850 Bench 
PECVD Reactor 
Six-way stainless steel cross vacuum chamber with a 16-in 
long, 2-in-diam Pyrex cylinder connected to the feedthrough 
port at the top. With a helical resonator discharge source using 
a radio-frequency (rf) powered copper coil at 13.56 MHz, and 
surrounded by a grounded cylindrical copper shield enclosing 
the Pyrex tube. The rf power, provided by a RF Plasma 
products model RF5S power supply 
L-B Trough Nima Technology, Model 611D 
Sonicator Fisher Sci. Model FS30 
pH meter Fisher Sci., Accumet 1003 
Water Bath Precision 180 series water bath, T range: RT + 5 to 100°C 
Miscellaneous 
All gas tight Hamilton syringes, Pipettes, Adjustable micro 
Ependorf pipetters; Autoclaved Pipette tips, Ependorf Micro 
Tubes (1000µL). Dessicator.  Mica. Silicon/Silica wafer. 
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5.2. Experimental Procedures 
5.2.1. Conditioning of Aβ Peptides and Synthesis of Structures 
  5.2.1.1. Aβ1-40 and Aβ1-42 Peptides 
Lyophilized peptide (1mg) kept at -20°C was removed from the freezer and let 
equilibrated for 30 minutes at room temperature (RT). The peptide is then dissolved in 
HFIP following the procedure described by W. Blaine Stine et al. [29].  HFIP is used to 
break any residual tertiary and β-sheet secondary structure of the peptide. The peptide is 
composed by α-helix  (~50-70%) and random coil (~30-50%) structures mainly [29]. The 
HFIP is then injected into the peptide flask with a gas-tight Hamilton 0.5ml glass syringe 
until a concentration of 3.33µg/µl is obtained. Peptide dissolution takes not longer than 
five minutes. Such stock solution is aliquoted into 25 parts and storage in sterile micro 
centrifuge tubes of 12.5µl, containing 40µg of Aβ each approximately. Thus, each micro 
tube contains 9.238 nmol and 8.861 nmol for Aβ (1-40) and Aβ (1-42), respectively. 
Aliquoted samples are left under the laminar-flow hood to allow the HFIP to evaporate. 
The peptides are then placed for 12 hours in a desiccator at a vacuum of 27 in Hg. The 
final peptide samples have an even appearance (i.e., transparent film), which is 
appreciated at the bottom of the Eppendorf tubes. The tubes with the peptide are flushed 
and closed with nitrogen, wrapped with aluminum foil and parafilm, and enclosed in a jar 
at -20°C for later used. 
5.2.1.2. Amyloid-β Conformations 
a. Monomers 
The following procedures are the same for both 1-40 and 1-42. 40µg of pretreated 
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Aβ peptide is removed from the freezer and let to equilibrate at RT.  The pretreated 
peptide is dissolved in 2µL of DMSO, which is a polar, water-soluble organic solvent 
commonly used to solubilize hydrophobic peptides. After a minute of sonication with 
DMSO, 88µL of milli-Q water are added to the sample. Finally, it is incubated at RT 
[29]. 
b. Oligomers 
First, a tris/NaCl/HCl buffer solution is prepared. This buffer serves as incubation 
media for the oligomer’s synthesis. The buffer is prepared in an Eppendorf of 50ml, 
where 0.3028g of tris and 0.2922g of NaCl are dissolved in DI water until the pH is fixed 
to 7.4. Sometimes a few drops of concentrated HCl need to be added. The pretreated 
peptide film kept at -20°C is then dissolved in 2µL of DMSO, sonicated for 1 min, and 
then incubated at 4°C in 88µL of Tris/NaCl/HCl. This procedure is described in detail by 
Kayed et al. [30]. 
c. Fibrils 
The first step to incubate Aβ fibril structures is to prepare a solution of 
ammonium hydroxide at pH=8.5. The next step is to prepare a PBS buffer. Fibrils are 
prepared by dissolving 40µg of the pretreated peptide (at RT) in 20µL of NH3OH and 
later adding 20µL of PBS. The sample is gently vortexed and finally incubated at a 
concentration of 1µg/µL at 37°C. This procedure was suggested by Dr. David Morgan 
(PhD) from the Department of Pharmacology & Therapeutics in the College of Medicine 
at the University of South Florida (USF), and director of the Alzheimer Research 
Laboratory at USF. 
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5.2.2. Surface Characterization of the Amyloid Peptides Topology 
The sample deposition procedure is conducted under laminar flow cabinet to 
avoid contamination by undesirable particles. The samples to be analyzed with the AFM 
are deposited on mica, which is an inert, smooth, and easily to clean mineral, and widely 
used for biological samples in AFM imaging. Mica sheets are freshly cleaved prior to 
each deposition. A small Teflon O-rings (external Φ 4.45mm, internal Φ 1mm) is used as 
an incubation chamber placed on top of the mica which ensure the maintenance of the 
desired location of fibril formation.  3µL of each incubated sample are dissolved with 
ultrapure water until a concentration of 20µM is reached. This concentration has been 
tested as the optimum to produce fibrils in a control manner.  A small drop of such 
solution is then deposited on mica and incubated for 5 min, flushed with 3mL of ultrapure 
water, dry with ultrapure nitrogen, and stored in a desiccator under vacuum (30 torr) for 
later AFM study.  
5.2.3. Chemical Characterization of Amyloid Peptides   
No fibrils were observed when Aβ40 peptide was incubated. Therefore, the 
chemical characterization was done only for Aβ42 peptide conformations. The chemical 
analysis is done using an ATR-FTIR spectrometer, and a zinc selenide ATR crystal. The 
ATR cell allows a maximum volume of 62µL solutions (Figure 19). The crystal was first 
cleaned with isopropanol, and then a fresh media solution was flushed before peptide 
contact.  The background for the IR data was taken when the ATR crystal was in contact 
with non-peptide media.  Spectra were taken at about 10 min intervals for about 3 hours 
for monomers, 10 hours for oligomers, and 12 hours for fibrils, which is the time that it 
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took for the samples to reach saturation and steady state conditions. This part of the study 
was conducted in the Materials Research Laboratory at the University of California-Santa 
Barbara (UCSB). 
5.2.4. Biomimetic Cell Membrane Construction and Studies of Interaction 
with Amyloid-β Peptide 
  5.2.4.1. Soft –Support Layer  
 Polyethylene glycol (PEG) is used to build the soft support layer.  PEG is a linear 
or branched neutral polyether soluble in water and most organic solvents.  Its chemical 
formula is: HO-(CH2CH2O)n-CH2CHOH.  PEG is utilized in this study because its 
biotechnical applications. In fact, Norma Alcantar and collaborator have studied this 
polymer widely [25] , including its use as cushion substrate or coating polymer.  PEG is 
unusually effective at excluding other polymers from its presence in aqueous solution, 
such as lipids. This property is directly related to the fact that PEG rejects proteins and 
forms two-phase systems with other polymers; it is nontoxic; it has immunogenicity and 
nonantigenicity; it does not harm active proteins or cells even if it interacts with cell 
membranes; it attaches to other surfaces with very little effect on their chemistry; and it 
increases the solubility of large molecules despite their size.  In addition, PEG coated 
surfaces become hydrophilic and protein rejecting. Therefore in our study we are insuring 
there is no absorption of the Aβ to the silica surface, if there is any adhesion, it is due to 
the interaction of the lipids themselves with this peptide. The inert character of PEG is 
based on its molecular conformation in aqueous solution, where PEG exposes uncharged 
hydrophilic groups and shows very high surface mobility (steric exclusion).  It is worth 
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mentioning that in order to maintain its biological and biocompatible properties, the PEG 
has to be chemically attached to the surface. PEG is grafted to silica films deposited on 
silicon wafers creating a thin hydrophilic film.  The silica deposition takes place reacting 
silane (SiH4) and O2 gases in a PECVD reactor (Figure 14). The samples are then 
exposed to a water plasma treatment in order to increase the hydroxyl group 
concentration on the surface controllably and reproducibly [25]. Finally, the surfaces are 
storage on a dry and free of particles container. 
Concentrated sulfuric acid is used for cleaning the surfaces by submerging them 
overnight, and then are rinsed with DI water, dried with ultrapure nitrogen, and exposed 
to UV-light for about 5 minutes. The reactivation is done by submerging the surfaces in a 
NaOH solution at 10 %w for about 5 minutes. The surfaces are then rinsed with water 
and dried very well, since any traces of water could interfere with the PEG reaction. In 
the meantime, a solution of PEG (of wt ~ 400Da) is heated until it reaches 100°C 
maintaining constant agitation. The cleaned and activated surfaces are placed into the 
PEG for one hour. These parameters have been determined previously by Alcantar et. al. 
[25]. Once the PEG grafting reaction is done, the surfaces are retrieved from the hot PEG 
and gently rinsed with water (avoiding direct contact with the flux o water), and dried 
with ultrapure nitrogen.  Sometimes the surfaces with PEG that are not used at the 
immediately after the reaction are storage in PEG media. 
5.2.4.2. Lipid Deposition 
The lipid bilayers are deposited onto the soft-support PEG layer using a Langmuir 
Blodgett (LB) trough (Figure 20). The first step is to ensure that the LB trough is 
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impeccable, since it is very important to avoid particles clinging to the surface. These 
particles can contaminate and perturb the deposition quality. To clean the trough, we use 
DI water and sometimes organic solvents. We look at the quality of the water by 
watching for bubble formation. Bubbles are a sign of contamination. A suction tube is 
used to eliminate these bubbles out of the water without touching the surface of the 
trough avoiding damage to the trough surface. The water is suctioned several times until 
non-bubbles are observed. 
 
Figure 20. Langmuir-Blodgett Trough. The principal components the trough are 
highlighted in this photo 
 
The LB trough is plugged to a computer that allows one to control parameters 
such as surface area, superficial tension, and substrate deepness necessary for the actual 
deposition. The trough is located inside of a laminar flow cabinet, which turn on when 
the trough is being cleaned. However, the air flow is off, while the lipids are being 
compressed or deposited. Once the water surface is clean, the surface pressure sensor is 
calibrated to 0 N/m. An isotherm is recorded using a velocity of 50 cm2/min. The trough 
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is clean and ready to used, if the isotherm is a straight line. The target surface is 
submerged for the deposition in the back socket of the trough. The trough is cleaned once 
more to avoid any possible particles introduced by the surface. Another isotherm is run to 
ensure cleanliness. The pressure is set to zero and the surface area is set to 300cm2.  The 
area, deposition pressure, and lipid concentration used for the depositions were chosen 
based on previous experiments. Typical lipid concentrations are 15 µg/µL. A total 
volume of 100 µL is gently spread on the air/water interface using a syringe (giving it 
about 5 minutes for the solvent to evaporate).  During the deposition, the surface pressure 
is kept constant at 30 mN/m.  The deposition takes place at constant pressure and using a 
barrier velocity of 50 cm2/min (Figure 21). 
 
Figure 21. Schematic of Lipid Bilayer Construction. (upper left) PEG grafting reaction, 
(upper right) bilayer deposition, and (bottom) soft supported bilayer 
 
5.2.4.3. Surface Topography 
The soft-supported membranes constructed above have also been scanned by 
AFM in solution. They are kept in contact with saturated lipid solution at all times to 
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avoid air exposed and consequently, damage to the sample (Figure 22). The biomimetic 
cell membranes were also scanned while in contact with Aβ fibrils (0.933 µM). Scans are 
shown and explained in the next chapter.  
 
 
Figure 22. Picture of the Wafer Contented in the Petri Dish. This is were the biomimetic 
membrane has been deposited 
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Chapter Six 
Results and Discussion 
This work is based on the fact that real interactions of Aβ peptides, with both 40 
and 42 amino acid sequences, could be controlled and studied by following a 
comprehensive approach.  The control on the structure of the Aβ peptides was done by 
optimizing the incubation conditions previously studied by Stine et al. [29] and Kayed et 
al. [30]. Depending on the conformation that is being pursued (i.e., monomeric, 
oligomeric and fibrillar), the peptide molecules will adopt diverse structures that defined 
their physical and chemical pathways of aggregation, which evolve with time. By tuning 
and promoting specific conformations, we were able to explicitly distinguish the response 
of the peptide in terms of their assembly, surface adhesion, chemical composition and 
kinetics. Explicitly, our results are three-fold:  
a. We resolved the differences of behavior depending on the number of amino acid 
residues contained in each peptide molecule (i.e., Aβ-40 and Aβ-42) 
b. We promoted structural rearrangement depending on the incubation media and 
substrate character 
c. We were able to correlate peptide structures (i.e., α-helix, β-sheet, β-turns, or 
random) with the adhesion dynamics and ultimately, to determine the role of 
molecular stability of the peptide that leads to the formation of the AD plaques. 
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6.1 Reaching the Overall Goal 
 According to the three aims that we set from the beginning:  
a. -- To study and compare conformation assembly for Aβ (1-40) and Aβ (1-42). 
b. -- To study the adhesion mechanisms: 
c. -- To study and understanding of fibrillar kinetics with model membranes: 
We have been able to achieve our goal of elucidating, from the physicochemical point of 
view, the implications of the stability and conformations of Aβ in the formation of AD 
plaques. 
6.2 Aβ (1-40) and Aβ (1-42): Study and Comparison of their Structure and Kinetics 
The three Aβ peptide conformations that were considered in this work are: 
monomeric, oligomeric and fibrillar. From the AFM data, we were not only able to 
directly measure the height and width that corresponds to each of these structures on rigid 
(mica) and soft supported (model membrane) substrates, but also, to understand how their 
assembly occur with time and how their height/width ratio relates to their kinetic 
mechanisms for both peptides.  
6.2.1 Aβ (1-40) vs. Aβ (1-42): Comparison of their Structure 
 The Aβ conformations were prepared on mica and analyzed by AFM. The 
samples were incubated as a function of time to observe the following processes: 
solubility, stability and dynamics of formation. The evolution of the monomers is shown 
below from their initial preparation until 72 hours of incubation in solution. The Aβ40 
compared to Aβ42 shows very little absorption with time. In addition, the Aβ40 
aggregates slowly into large clusters, with no indication of fibrillar structures being ever 
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formed (Table 4). On the contrary, the Aβ42 evolve in two different stages where an 
initial effect took place dominated by dissolution of the molecule, and the formation of 
thin large fibrils resulted between 9 and 20 hours of incubation.  
Table 4. Amyloid-β Peptides 40 and 42, Monomeric Stability Comparison 
Peptide EVOLUTION TIME [hours] 
Aβ 0 5 9 
40 
 
42 
 
 20 48 72 
40 
 
42 
 
The scan size for all the images is 2 µm and the height scale is indicated by the bar at the 
right hand side of each picture. 
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Likewise, oligomeric structures show similar results, where the Aβ40 did not 
form fibrillar conformations but clusters. Again, the Aβ42 formed fibrillar structures after 
9 hours of incubation (Table 5). 
Table 5. Amyloid-β (1-40) and (1-42), Oligomers Formation and Stability 
Peptide EVOLUTION TIME [hours] 
Aβ 0 5 9 
40 
  
42 
  
 15 25 > 25 
40 
 
They did no form fibrils 
42 
 
More and longer fibrilliar 
conformations were 
observed 
Similarly, scan size for all the images is 2 µm and the height scale varies from each 
picture and is indicated by the bar at the right hand side of each picture. 
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In the case of fibrilliar structures, the Aβ40 behaves in the same way as for 
monomers and oligomers. It was very surprising that almost no fibrils were detected, 
although the incubation conditions should have produced them. On the contrary, fibrils 
were observed on the Aβ42 after 10 hours of incubation (Table 6). 
Table 6. Amyloid-β (1-40) and (1-42), Fibrils Formation and Stability 
Peptide EVOLUTION TIME [hours] 
Aβ >5 10 15 
40 
  
42 
  
 20 48 91 
40 
   
42 
   
Scan size is 2 µm and the variable height scale as indicated on each picture. 
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 A very interesting result display by the Aβ42 fibrils is that they are intrinsically 
different for each structure. In other words, if we look at the scans after 20 hours of 
incubation time, the fibrils formed by the oligomers are thicker than that formed by fibrils 
or monomeric precursors. In addition, the fibrils formed at longer times seem to be 
similar in thickness and shape. This indicates that the preferential structure independently 
of the precursor molecules for the Aβ42 is fibril conformation. 
In order to compare the evolution of the topography of Aβ structures 
quantitatively, we have measured and compared the average ratios between height and 
width for each scan, which relates to the affinity of adhesion and surface density. Details 
about how these values were calculated are shown in the Appendix F section. 
This analysis indicates that two of the three structures undergo a conformation 
change at 11 hrs for monomers and 18 hrs of incubation for oligomers for both Aβ40 and 
Aβ41, which corresponds to taller fibrils while the thickness remains low. This 
conformation change (maximum point) determines a saturation point, where the fibrils 
seem to pile up instead of spreading on the substrate. After that, both molecules show that 
the fibrils continue spreading onto the surface again. However, for fibril structures the 
behavior is very different. The Aβ40 and Aβ42 show opposite performance. In addition, 
we observed three interesting stages, one at 4, one at 10 and one at ~48 hours. The one at 
4 and 50 hours correspond to a maximum in the Ratio value for Aβ40, but a minimum 
values for Aβ42. This is also related to the saturation of the surface as explained above. 
At 10 hours both peptides show similar surface density and topography. 
 
 54
 
6.3. Chemical Characterization of Aβ (1-42) Peptide Conformations 
By using the ATR-FTIR technique, we are able to recognize the type of 
conformation that each precursor molecule has as a function of time. This study shows 
the evolution and dynamics of each chemical structure as a function of incubation 
conditions. We were able to distinguish specific structures depending on the IR vibration 
modes of the peptides. These structures show well defined processes indicating its 
dilution, molecular arrangement, and a steady state (equilibrium). 
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Prior to present this analysis; let’s define the ranges of wavenumber used to 
classify the existence of determined structure (Table 7). 
Table 7. Amide I and II IR Regions for Peptide Molecules 
Structure Wavenumber (cm-1) 
Amide I region3  
Beta turn  1695-1670 Intermolecular β-structure  
1690-1680 Intramolecular β-structure 
Random coil 1645-1648 
Alpha helix  1657-1648 
Beta sheet 1640-1630 Intramolecular β-structure  
1625-1610 Intermolecular β-structure 
Amide II region4 
NH2 deformations 1567 N-H bending (60%);  
C-N stretching (40%) 
Related to proteins absorption/desorption centered at 1550  
 
From the FTIR spectra, a deconvolution of the absorbance data was performed to 
differentiate from all the structures present in each conformation.  The deconvolution 
analysis is done with Origin version 6.1. A sample of how this analysis was done is 
presented in Figure 24. This corresponds to a sample of fibrillar structures at initial 
conditions.  
 
 
 
 
                                                 
3 Amide I region is  between 1600 and 1700 cm-1   
4 Amide I region is  between 1600 and 1700 cm-1   
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Chi^2/DoF 9.69E-07  
R^2 0.99992  
ID 
Theoretical
Value Error 
y0 0 0
xc1 1645.83 1.31298
w1 68.00513 0.93894
A1 22.11764 0.87222
xc2 1631.015 0.46575
w2 30.44602 1.25849
A2 3.01095 0.48154
xc3 1595.676 2.49805
w3 28.66821 5.90861
A3 0.34583 0.25173
xc4 1558.676 2.86705
w4 59.33113 2.82359
-0.05
0
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0.1
0.15
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0.35
1500 1550 1600 1650 1700 1750
A
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nc
e 
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.u
.)
Wavenumber (cm-1)
1645cm-1
1631cm-11595cm-1
1558cm-1
A4 2.51592 0.25166
 
Figure 24. Example of the Deconvolution for Fibrils at Initial Conditions. The 
black line represents original data; the red line one represents the outcome of the 
deconvolution fitting. The resulting peaks are shown in green 
 
6.3.1. Monomeric Conformation 
Figure 25, shows the time evolution spectra for monomeric conformation of Aβ 
(1-42) peptides. Spectra were taken from its initial preparation until about 150min of 
incubation time. This time interval was chosen based on the AFM analysis. Iit was 
observed that fibrils did not form during this time (Table 4). Two particular regions are 
observed corresponding to the Amide I and II.  The amide I band, between 1600 and 
1700 cm-1, is associated with the backbone conformation of the peptide (-Cα=O). Amide 
II results from the N-H bending vibration (40-60%) and from the C-N stretching 
vibration (18-40%), and is sensitive to the structural configurations.  
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Figure 25. FTIR Spectra of Amyloid-β (1-42) Peptide Monomeric Precursors 
The deconvolution analysis of these peaks based in the assignment from Table 6 
appears in the next Table, which the evolution of the various species from initial 
conditions until 150 min of incubation time. 
The N-H bending and C-N stretching (Not-shown), progressively decrease with 
time until they equilibrate after the transition process (>100 min). 
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Table 8. Evolution of Individual Conformations for Monomeric Precursors 
0 0.02 0.04 0.06 0.08 0.1
0
15
30
45
60
75
100
105
120
135
150
Integrated absorbance (a.u)
Ti
m
e 
(m
in
)
Steady state 
Peptide 
rearrangement 
Dilution
 
0 0.1 0.2 0.3 0.4 0.5 0.6
0
15
30
45
60
75
100
105
120
135
150
Integrated absorbance (a.u.)
Ti
m
e 
(m
in
)
Peptide 
rearrangement  
& steady state 
Dilution
 
Intermolecular β-turns: Three stages can 
be seen: 1) dilution process, from 0-30 
min., 2) peptide rearrangement, after 45 
minutes there is a steady increase of this 
structure, and 3) equilibrium process, from 
100 min to 150 
Intramolecular β-turns: Notice a decrease 
in the amount of this type of structure from 
0 to 30min, which is associated with the 
dilution zone. > 45 min, the protein steadily 
reaches a stable concentration. The amount 
of β turns decays during monomeric 
evolution 
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0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4
0
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Integrated absorbance (a.u.)
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)
Dilution 
Peptide 
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α-helix structure: After dissolution stage, 
these structures are suddenly visible. They 
appear in the transition process, and 
disappear again coinciding with the 
formation of β sheets 
β sheets structures: Increase continuously 
until they reaches an equilibrium state (> 
105 min). The sudden shift corresponds to 
the lost of α-helix structure 
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6.3.2. Oligomeric Conformations 
The oligomeric precursors were studied from initial conditions until after 9 hours 
(Figure 26). Remember that between 10 to 15 hours, the oligomers started producing 
fibrillar conformations as shown Table 5.  Overall, the IR spectra clearly demonstrated 
that the oligomeric species are centered in the Amide I (1685-1670 cm-1). This is region 
was deconvoluted into two regions that correspond to β turns both inter- and intra-
molecular (Table 9). In addition, there is a well defined region that can be assigned to 
Amide II (1567-1500 cm-1), and corresponds to the absorption process of oligomeric 
structures onto a substrate. Similarly to the monomeric species, these molecules undergo 
a dissolution process initially (0-3 hours). The absorption process accelerates with time 
until it reaches equilibrium from about 3 hours until after 9 hours of incubation.  
0
0.05
0.1
0.15
0.2
0.25
0.3
150015501600165017001750
A
bs
or
ba
nc
e 
(a
.u
.)
Wavenumber (cm-1)
0min
60min
120min
180min
540min
 
Figure 26. Structures Evolution with Time of Oligomeric Precursors of Aβ (1-42) 
Peptides 
 
 60
Table 9. Evolution of Individual Conformations for Oligomeric Precursors 
0 2 4 6 8 10 12 14
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Dilution and peptide 
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Intermolecular β-turns: Two stages can 
be seen: 1) dilution process, which also 
includes the rearrangement of the peptide 
molecules and, 2) steady state equilibrium 
Intramolecular β turns:  Similar behavior 
as for intermolecular β turns. It is amazing 
how both structures follow parallel paths 
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NH2 deformations: Taken from the Amide 
II region, two stages are seen as function of 
time, where they follow similar formation 
and transition paths 
Absorption/desorption process: It is clear 
that oligomeric species deposit on the 
substrate surface. Very good agreement 
with AFM data (Table 5). 
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6.3.3. Fibril Conformation 
The time evolution of fibrillar species is a little bit more complicated than for 
that for other configurations, because they show a longer dissolution processes, a 
transition process, an a state where some chemical conformation reach equilibrium 
but other molecules keep changing and do not reach a constant dynamics. The IR 
spectra show a very interesting behavior. First, the regions assigned to β-sheet decays 
with time, where as the Amide II region decreases and reaches an equilibrium state. 
This indicates two processes, one, the β sheets are evolving and are been redistributed 
or transformed into other chemical conformations. Second, the fibrils form and 
absorbs onto the surface in the first 3 hours (Table 10). After that, they rearrange or 
chemical alter while being attached to the substrate. This is a very important finding 
since indicates that the fibrils may form in solution, but they form, react and 
transform even after being absorb on a surface (Figure 27). 
 
Figure 27. Time Evolution Spectra of Fibril Structures of Aβ (1-42) 
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Table 10. Evolution of Individual Conformations for Fibrillar Precursors 
0 2 4 6 8 1 0
0
3 0
6 0
9 0
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β sheets: Two types of behavior are 
visible, 1) during the dissolution, the 
conformations are mainly intramolecular 
structures (1640-30cm-1), and 2) steady-
state existence of intermolecular 
conformations (1625-10cm-1) 
Absorption/desorption process:  
As explained before, the fibrils absorb 
during the first 3 hours and after that, they 
stop absorbing but they change 
conformation while being adhered to the 
substrate 
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 The N-H bending and C-N stretching behavior shows a constant dynamics that 
varies with respect to the other species. The interactions come and go according to the 
dissolution and transition processes. 
 We found an astonishing behavior when we determine the integrated absorbance 
for each structure in time. The fibrils and oligomers go from a maximum energetic level, 
when they just started dissolving, to a lower region when formation/absorption 
mechanisms are competing with each other.  This change of energy takes place in the first 
three hours of formation. On the other hand, monomeric precursors do not change with 
time but after 3 hours, they start degenerating.   
 
Figure 28. Comparison of Surface Dynamics for the Three Peptide Structures: Integrated 
Absorbance Evolution with Time 
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6.4. Membrane Construction 
 One of the goals of this research is to study the interactions of fibril structures 
with model membranes. The membranes are prepared by using L-B deposition techniques 
on rigid and soft supported surfaces. The lipid membranes were constructed with DSPE 
and its surface stability was studied as explained next.  
 At the air/water interface, we observed the behavior of DSPE layers as a function 
of lipid concentration. We found that the optimum concentration for the deposition of the 
layers was 2.45mg/mL, and the optimum surface pressure should be between 20-40 
mN/m. Other concentrations resulted on weaker layers or limited the areas to perform the 
transfer of the lipid layers to a substrate (Figure 29).  
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Figure 29. Surface Tension of DSPE as a Function of Lipid Concentration. Low 
concentrations resulted in low ordering, and high concentrations resulted in rigid and 
fragile layers 
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Once the optimum concentration was determined, we performed 
loading/unloading cycle to test the response of the layer to dynamic changes. We 
observed that this concentration also promote stable layers (Figure 30).  
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Figure 30. Loading/Unloading Cycle for DSPE at 2.45mg/mL and 30mN/m 
 The layers were transferred to the PEG/silica substrates with a transferred ration 
of 99.94%. The pressure-area (π-A) isotherm is shown in Figure 31 for our system. Once 
the layers were deposited we look at them using AFM in lipid rich-aqueous solutions. 
The images of the membranes show a layer that has high mobility (Figure 32a). This 
layer was then exposed to a very high concentration of fibrillar solution and then scanned 
in situ. We found that initially, some fibril structures deposited on the surface of the 
membrane (Figure 32b). However, they did not stay absorbed for very long. We believe 
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that the mobility of the layers influence the absorption mechanism to which this fibrils 
attach to surfaces, since the fibrils did not appear in further scans of the model membrane 
surface (Figure 32c). 
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Figure 31. Deposition and Transfer of the Lipid DSPE Bilayer onto the PEG/silica 
Substrates to Create the Model Membranes 
 
 
 
 
 
 
 
 
Figure 32. Interacting Mechanisms Between Lipid Bilayers and 
Aβ (1-42) Peptide Fibrils Using AFM Liquid Imaging. (a) 10 by 10 µm scan of the model 
membrane surface as deposited, (b) Scan after fibrils have been added to the membrane, 
and (c) Scan soon after fibril exposure. The fibril structures refused to adhere on the 
surface possibly owing to the surface mobility of the soft-supported membranes 
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 One of the questions is if the fibrils really are influenced by the mobility of the 
membrane. Let’s look at the section scan from Figure 32b (Figure 33) to analyze such 
behavior. The height of the fibrils corresponds to 6nm, which happens to match the 
height of the fibers adhered to rigid supports also detected by AFM (Table 4, 5, and 6). 
Therefore, it is reasonable to assume that the fibers indeed adhere to cell membranes, but 
the surface mobility makes such adhesion very weak. This is an important finding since 
the implications of finding the molecular mechanism of Aβ peptides to membranes may 
lead us to determine the processes that control fibril adhesion and plaque formation. That 
is, these findings might lead us in a direction to find release mechanisms that will prevent 
or stop adhesion all together.  
 
 
 
Figure 33. Section Profile of Biomimetic Membrane Surfaces in Contact with Fibrils. 
The height of the fibrils average 6nm, which corresponds to the values report elsewhere 
and reported early in this chapter (See Table 6) [23, 26] 
 68
 
 
 
Chapter Seven 
Conclusions and Future Work 
7.1 General Findings and Conclusions 
 This project had a very well defined goal from the beginning, which was to study, 
control and determine the implications of having three different structures of the two 
peptides that are most influential in AD brain’s dysfunction, the Aβ-40 and Aβ-42. We 
were able to establish the procedures to prepare stable and reproducible configurations of 
Aβ peptides, so that we could study their interactions with biomimetic membranes. 
The most important findings in terms of amyloid beta peptide adhesion to surfaces 
are as follow: 
a. There is a distinct trend between the Aβ1-40 and Aβ1-42 in terms of adhesion to 
rigid surfaces.  Aβ1-40 exhibits a poor adhesion to mica, whereas Aβ1-42 shows a 
strong adhesion to rigid supports.  This difference in adhesion behavior may be 
correlated to the toxicity and propensity to form longer aggregates that ultimately 
form fibrils and plaques in normal conditions, since our ATR data shows that 
fibrillar configurations have a very complex adhesion mechanism to surfaces.  
b. The Aβ1-40 show to be more stable in terms of aggregation. In most cases, this 
peptide did not form fibrillar structures even though the conditions to form them 
were heavily induced. 
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c. There is a strong correlation between data from the two surface analytical 
techniques used in this project. AFM and FTIR data show the effect of a dilution 
process. This mechanism takes place in the first 30 min. of precursor incubation. 
However, it has a great impact in the evolving time to achieve equilibrium state. 
There was a transition zone where the structures of the peptides rearrange and 
most of the conformations decrease or increase at this time (between 1-3 hours). 
d. In the case of the Aβ1-42, the formation of bigger aggregates into fibrillar 
configurations started to take place > 9 hours of incubation for most cases. 
e. We were able to correlate the individual configurations of these molecules with 
kinetics and dynamics of adhesion.  
f. We were able to control fibril formation or fibrilogenesis, since it was shown that 
nonfibrillar assemblies were maintained and studied in vitro.  
g. The adhesion process of fibrillar structures and aggregates is very complex and 
depends on the preparation conditions and the affinity of the peptide to surface 
structure. 
h. We were able to distinguish between intermolecular β turn structures (1695-1670 
cm-1), intramolecular β turn structures (1690-1680 cm-1). Typically, these 
structures are not seen in protein conformation studies. 
i. AFM studies illustrate how oligomeric and monomeric configurations of Aβ-40 
and 42 follow a general trend in terms of their ratio of height and width. That is, 
they absorbed onto themselves instead of the substrate until saturation is reached. 
Only after that the peptide will continue absorbing onto the substrate.  
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j. For fibril configurations, the ratio of height/width of Aβ-40 and Aβ-42 follows an 
inversely proportional trend. 
k. Biomimetic membranes can be built onto PEG layers to mimic real surface 
mobility. 
l. The interactions between biomimetic membranes and fibrils show that the fibrils 
initially absorb, but that the absorption is very weak. This may be a function of 
surface flexibility and softness created by the PEG underneath layer.  
m. By comparing the adhesion behavior of the fibril to the mica with the adhesion 
behavior to biomimetic membranes, we concluded that the rigidity of the substrate 
indeed is plays an important role in the adhesion mechanisms of the fibrils. 
n. These findings led us to hypothesize that normal fibrils attach to real cell 
membranes because they have lost mobility somehow. It has been discussed that 
cholesterol may have an important role in AD plaque formation. This hypothesis 
agrees with the literature studies were Statins have helped to reduce the effects of 
AD symptoms [31-33]. 
7.2   Final Remarks and Future Work 
a. This work has advanced our ability to master a systematic way to prepare the 
three different conformations of Aβ peptides that may play an important role in 
AD plaque formation. 
b. If these three conformations may influence plaque formation, we may be able to 
understand the molecular mechanisms associated with their adhesion, surface 
kinetics and assembly processes by using the Surface Forces Apparatus and the 
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ATR-FTIR technique concurrently (IR-SFA). 
c. Further investigation developing essays with the two peptides together is needed 
to elucidate why only Aβ42 segments cause adhesion, and how they influence 
Aβ40 peptide dynamic processes.  
d. Additional studies to corroborate our initial findings on the effect of substrate 
mobility will be performed. For instance, we would like to vary systematically the 
rigidity of model membranes by introducing cholesterol in their structure. 
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Appendix A. Milestones Toward Formulating and Testing the Aβ Hypothesis of AD[9] 
1892-1907 Lesions associated with Alzheimer’s neurodegeneration described and categorized 
(Alzheimer 1907; Blocq and Marinesco 1892; Redlich 1898) 
1920-40 Amyloid plaques and perivascular deposits described and proposed to adversely 
affect cerebral function (Divry 1927; Scholz 1938) 
1970-86 Isolation (Nikaido et al. 1971), amino acid composition (Allsop et al. 1983; Roher 
et al. 1986, Selkoe et al. 1986) and N-terminal sequences of perivascular (Glenner 
and Wong 1984) and parenchymal plaque Aβ (Masters et al. 1985)  
1987-88 Amyloid precursor protein (APP) gene cloned, located on chromosome 21 and Aβ 
recognized as putative proteolytic product (Kang et al. 1987; Tanzi et al. 1987, 
1988; Goldgaber et al. 1987; Robakis et al. 1987; Kitaguchi et al. 1988; Ponte et 
al. 1988) 
1989-99 Toxicity of Aβ in cell culture (Whitson et al. 1989; Yankner et al. 1989), 
mediated by oxidative processes (Behl et al. 1992, 1994; Dyrks et al. 1992; 
Butterfield et al. 1994) and metals (Bush et al. 1994; Schubert and Chevion 1995; 
Huang et al. 1999; Cherny et al. 1999) 
1990-92 Mutations in proximity to Aβ secretase sites cause AD (Levy et al. 1990; 
Chartier- Harlin et al. 1991; Goate et al. 1991; Murrell et al. 1991; Citron et al. 
1992; Hendriks et al. 1992) and confirm centrality of Aβ hypothesis  
1992-93 Aβ and p3 identified as definite proteolytic products from APP (Seubert et al. 
1992, 1993; Shoji et al. 1992; Busciglio et al. 1993) 
1992-93 ApoE identified as an Aβ-interacting protein (Wisniewki and Frangione 1992; 
Strittmatter et al. 1993) and its alleles identified as genetic risk factors in sporadic 
forms of AD (Coder et al. 1993) 
1991-97 Transgenic mouse models of Aβ deposition (Quon et al. 1991; Borchelt et al. 
1997; Sturchler-Pierrat et al. 1997; Games et al. 1995; Hsiao et al. 1996) 
1995-2000 Presenilins recognized as major components in the amyloidogenic pathway 
(Levy-Lahad 1995; Borchelt et al. 1996; Sherrington et al. 1995; Rogaev et al. 
1995; Scheuner et al. 1996), probably acting as γ-secretases (Ray et al. 1999; 
Capell et al. 2000; Kimberly et al. 2000; Jacobsen et al 1999; Octave et al. 2000; 
De Strooper et al. 1998, 1999; Wolfe et al. 1999a, b; Steiner et al. 1999. 
1998-99 α-secretases identified (Buxbaum et al. 1998; Lammich et al. 1999) 
1999-2000 Major Aβ degradative and clearance pathway identified (Iwata et al . 2000; Qiu et 
al. 1999; Vekrellis et al. 2000) and improved clearance of Aβ from the brain by 
immunization with Aβ (Schenk et al. 1999) 
1999-2000 β-secretases identified (Vassar et al. 1999; Yan et al. 1999; Sinha et al. 1999; Lin 
et al. 2000; Hussain et al. 1999) 
1995-2000 First rational anti-amyloid therapeutic strategies (Higaki et al. 1995) and 
commencement of early phase human trials (Bristol Myers Squibb, Elan 
Pharmaceuticals, Prana Biotechnology) 
 
 
 
 78
Appendix B. The 20 Protein Amino Acids  
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Appendix C. Chemical Forces and their Relative Strengths and Distances  
 
Force  Strength 
(kJ/mol) 
Distance 
(nm) 
Description 
Van der Waals 
interactions 
0.4 - 4.0 0.2 Strength depends on the relative size of the atoms or 
molecules and the distance between them. The size factor 
determines the area of contact between two molecules: the 
greater the area, the stronger the interaction. Attractive force 
is inversely  proportional to the sixth power of the distance, r, 
separating two atoms or molecules: F ≈ 1/r6.  
Hydrogen bonds  12 – 30 0.3 Relative strength is proportional to the polarity of the H bond 
donor and H bond acceptor.  More polar atoms form stronger 
H bonds. 
Ionic bonds 20 0.25 Strength also depends on the relative polarity of the 
interacting charged species.  Some ionic bonds are also H 
bonds: −− −+ OOCNH ...3  
Hydrophobic 
interactions  
< 40  - Force is a complex phenomenon determined by the degree to 
which the structure of water is disordered as discrete 
hydrophobic molecules or molecular regions coalesce.  
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Appendix D. Infrared Spectra  
Appendix D.1. Characteristic Infrared Bands of Proteins [28]  
Amino acid Wavenumber (cm-1) Assignment 
A 3300 N-H stretching in resonance with overtone 
B 3110 (2 x amide II) 
I 1653 80% C=O stretching; 10% C-N stretching; 10% N-
H bending  
II 1567 60% N-H bending; 40% C-N stretching 
III 1299 30% C-N stretching; 30% N-H bending; 10% C=O 
stretching; 10% O=C-N bending; 20% other  
IV 627 40% O=C bending; 60% other  
V 725 N-H bending  
VI 600 C=O bending  
VII 200 C-N torsion 
 
 
Appendix D.2. Characteristic Infrared Bands of Amino Acid Side Chains [28]  
Amino acid Wavenumber (cm-1) Assignment 
Alanine 1465 CH2 bending 
Valine 1450 CH3 asymmetric bending 
Leucine 1375 CH3 symmetric bending 
Serine 1350-1250 OH bending 
Aspartic acid 1720 C=O stretching 
Glutamic acid 1560 
1415 
CO −2  asymmetric stretching 
CO −2  symmetric stretching 
Asparagine 1650 C=O stretching 
Glutamine 1615 NH2 bending 
Lysine 1640-1610,1550-1485 
1160,1100 
NH +3  bending 
NH +3  rocking 
Phenylalanine 1602,1450,760,700 Benzene ring vibrations 
Tyrosine 1600,1450 Benzene ring vibrations 
Arginine 1608,1586 Benzene ring vibrations 
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Appendix E. Material Safety Data Sheets.  
Appendix E.1. Aβ1-40 
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Appendix E.1. (Continued) 
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Appendix E.1. (Continued) 
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Appendix E.2. Aβ1-42 
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Appendix E.2. (Continued) 
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Appendix E.2. (Continued) 
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Appendix F. One Example on AFM Data Processing  
I. Amyloid β (1-40) Monomer 0 hours (File: ab40-monomer-0h-2um) 
  
 
 
a. Group A: 
 
  
H1 
H2 
W1 W2 
A 
B 
C 
A 
B C 
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b. Group B: 
 
 
 
 
c. Group C: 
 
 
 
 
 
 
 
 
H1 
H2
W1 W2
H1 
W1 
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Appendix G. Transferred Area Calculation 
Transferred Rate Area (ATR) : 
  ATR = data) from (read ed transferrarea
alculated) tweezer(cand  wafers the toarea ed transferrtotal * 100% 
From Figure 31, one can see the transferred area, this is  
Transferred area= (the initial area at which 30mN/m is reach – 
 final area after deposition) 
Hence, 
Transferred area= 230.37 cm2 –177.32 cm2 = 53.05 cm2 
Now the wafer’s dimension were  
 
                           
                 1.912cm                                       with a thickness of .05 cm  
 
      1.912cm 
The total area for the wafer is 
 Awafer = 2*(1.912cm)2 + (0.05cm*1.912cm)*4 = 7.7cm2 
The deposition was done to two wafers at the same time with the same dimension, 
therefore the total area transfer to the wafer twice because we are building a bilayer, is; 
Atransfer to the wafer s (bilayer) = 7.7cm2 * 4 = 30.8cm2 
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Appendix G. (Continued)  
 
Next we need to calculate the area transferred to the tweezers use to hold the wafers, and 
the dimensions were: 
                       1.31 cm                               1.31 cm 
                                    
                                            1.896cm                        1.189 cm 
                                        Thickness= 0.5                Thickness= 0.2                 
    Area of 1: 
       A1 =           (1.31 cm  * 1.896 cm) * 2 = 4.97 cm2 
                  +     (0.5 cm * 1.31 cm)* 2 = 1.31 cm2 
                          (0.5cm * 1.896) = 0.948 cm2 
 
Total area 1:   A1 = 7.23 cm2 
Area of 2: 
         A2 =           (1.31 cm  * 1.189 cm) * 2 = 3.12 cm2 
                     +    (0.2 cm * 1.31 cm)* 2 = 0.524cm2 
                            (0.2cm * 1.189) = 0.2378 cm2 
 
Total area 1:        A2 = 3.88 cm2 
 
 
   2       1 
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Appendix G. (Continued)  
Total area transferred to the tweezers=  2* A1 + A2  = 22.22cm2 
Total transferred area is: 
           Area transferred to the wafers + area transferred to the tweezers= 
         Atotal transferred = 30.8 cm2 + 22.22cm2 = 53.02 cm2 
Hence the transferred rate is:            
 ATR = 2
2
cm 52.03
cm 52.02 * 100% = 99.94%  
 
 
 
 
